Variable | Univariate analysis | Multivariate analysis | |
---|---|---|---|
P value | Odds ratio (95% CI) | P value | |
Sex: men vs. women | 0.617 | ||
Age (years): >65 vs. ≤65 | 0.889 | ||
Heredity: yes vs. no | 0.553 | ||
Etiology: cryptogenic vs. HBV vs. HCV vs. schistosomiasis | 0.414 | ||
Tumor location: favorable vs. unfavorable | 0.177 | ||
Child–Pugh class: A vs. B | 0.029 | 0.787 (0.521–1.190) | 0.256 |
HBV-DNA: positive vs. negative vs. absence | 0.086 | ||
Antiviral therapy: yes vs. no | 0.179 | ||
ALT (U/L): <40 vs. 40–80 vs. >80 | 0.117 | ||
TBIL (μmol/L): ≤20 vs. >20 | 0.117 | ||
DBIL (μmol/L): ≤7 vs. >7 | 0.022 | 1.237 (0.939–1.629) | 0.130 |
ALB (g/L): <35 vs. ≥35 | 0.105 | ||
GGT (U/L): <50 vs. 50–100 vs. >100 | 0.268 | ||
PLT (×109/L): <100 vs. ≥100 | 0.073 | ||
PT (s): ≤13 vs. >13 | 0.157 | ||
AFP level (μg/L): <20 vs. 20–200 vs. >200 | <0.001 | 1.370 (1.178–1.593) | <0.001 |
CA19-9 (kU/L): ≤39 vs. >39 | 0.772 | ||
TA modality: MWA vs. RFA | 0.309 | ||
Initial local efficiency: complete vs. incomplete ablation | 0.429 |